Clinimetric dilemmas in outcome scales for mental disorders

Psychotherapy and Psychosomatics

Volumn 85, Issue 6, 2016, Pages 323-326

  Bech, Per ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DISCRIMINANT ANALYSIS; HUMAN; LIKERT SCALE; MENTAL DISEASE; MENTAL DISEASE ASSESSMENT; MULTIDIMENSIONAL SCALING; OUTCOME ASSESSMENT; PATIENT-REPORTED OUTCOME; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; REMISSION; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MENTAL DISORDERS; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOTHERAPY;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 84991786771     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000448810     Document Type: Review

References (30)

1. Parloff MB, Kelman HC, Frank JD: Comfort, effectiveness, and self-Awareness as criteria of improvement in psychotherapy. Am J Psychiatry 1954; 111: 343-352.
2. Bech P: Rating Scales for Psychopathology, Health Status and Quality of Life. A Compendium on Documentation in Accordance with the DSM-III-R and WHO Systems. Berlin, Springer, 1993.
3. Derogatis LR, Lipman RS, Covi L: SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull 1973; 9: 13-28.
4. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
5. Hamilton M: Diagnosis and rating of anxiety. Br J Psychiatry (spec publ) 1969; 3: 76-79.
6. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5 (DSM-5). Washington, American Psychiatric Association, 2013.
8. Paris J: The Intelligent Clinician s Guide to the DSM-5. Oxford, Oxford University Press, 2013.
9. Greenberg G: The Book of Woe. New York, Penguin, 2013.
10. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R; PROMIS Cooperative Group: The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010; 63: 1179-1194.
11. ICHOM: International Consortium for Health Outcomes Measurement (ICHOM), 2016. http://www.ichom.org/ (accessed June 28, 2016).
12. Piolanti A, Offidani E, Guidi J, Gostoli S, Fava GA, Sonino N: Use of the Psychosocial Index (PSI), a sensitive tool in research and practice. Psychother Psychosom 2016;85:337-345.
13. Bech P: Clinical Psychometrics. Oxford, Wiley-Blackwell, 2012.
14. Topp CW, Ostergaard SD, Sondergaard S, Bech P: The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom 2015; 84: 167-176.
15. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK; Fava M, STAR D Study Team: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40.
16. Carrozzino D, Vassend O, Bjorndal F, Pignolo C, Olsen LR, Bech P: A clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R) in general population studies (Denmark, Norway, and Italy). Nord J Psychiatry 2016; 70: 374-379.
17. De Vellis PF: Scale Development. Theory and Application, ed 3. London, SAGE, 2012.
18. Mechanic D: Sociological dimensions of illness behavior. Soc Sci Med 1995; 41: 1207-1216.
19. Sirri L, Fava GA, Sonino N: The unifying concept of illness behavior. Psychother Psychosom 2013; 82: 74-81.
20. Bech P, Rickels K: The items predicting nonremission after 6 months of treatment of patients with Generalized Anxiety Disorder covered the Eysenck neuroticism components of anxiety, interpersonal sensitivity and depression. Psychother Psychosom 2016; 85: 229-230.
21. Bech P, Kessing LV, Bukh JD: The validity of dysthymia to predict clinical depressive symptoms as measured by the Hamilton Depression Scale at the 5-year follow-up of patients with first episode depression. Nord J Psychiatry 2016, Epub ahead of print.
22. Cosci F, Fava GA: The clinical inadequacy of the DSM-5 classification of somatic symptom and related disorders: an alternative trans-diagnostic model. CNS Spectr 2016; 21: 310-317.
23. Eysenck H, Fulker D: The components of type A behaviour and its genetic determinants. Act Nerv Super (Praha) 1982; 3(pt 1):111-125.
24. Aronowitz RA: Making Sense of Illness. Cambridge, Cambridge University Press, 1998.
25. Vassend O, Skrondal A: The problem of structural indeterminacy in multidimensional symptom report instruments. The case of SCL-90-R. Behav Res Ther 1999; 37: 685-701.
26. Bech P, Bille J, Moller SB, Hellstrom LC, Ostergaard SD: Psychometric validation of the Hopkins Symptom Checklist (SCL-90) subscales for depression, anxiety, and interpersonal sensitivity. J Affect Disord 2014; 160: 98-103.
27. Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB: Advances in patient-reported outcomes: the NIH PROMIS ® measures. EGEMS (Wash DC) 2013; 1: 1015.
28. Strupp HH, Horowitz LM, Lambert MJ (eds): Measuring Patient Changes in Mood, Anxiety, and Personality Disorders. Toward a Core Battery. Washington, American Psychological Association, 1997.
29. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF; ACNP Task Force: Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 2006; 31: 1841-1853.
30. Kyle PR, Lemming OM, Timmerby N, Soendergaard S, Andreasson K, Bech P: The validity of the different versions of the Hamilton Depression Scale in separating remission rates of placebo and antidepressants in clinical trials of major depression. J Clin Psychopharmacol 2016; 36: 453-456.